Showing codes C9081 (Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose) — C9138 (Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.)

C9081 - Idecabtagene car pos t
Long description: Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9082 - Inj dostarlimab-gxly, 100 mg
Long description: Injection, dostarlimab-gxly, 100 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9083 - Inj, amivantamab-vmjw, 10 mg
Long description: Injection, amivantamab-vmjw, 10 mg
Code added date: 20211001.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9084 - Loncastuximab-lpyl, 0.1 mg
Long description: Injection, loncastuximab tesirine-lpyl, 0.1 mg
Code added date: 20211001.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9085 - Inj avalglucosid alfa-ngpt
Long description: Injection, avalglucosidase alfa-ngpt, 4 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9086 - Inj, anifrolumab-fnia
Long description: Injection, anifrolumab-fnia, 1 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9087 - Inj cyclophosphamd auromedic
Long description: Injection, cyclophosphamide, (auromedics), 10 mg
Code added date: 20220101.
Code effective date: 20220401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9088 - Instill, bupivac and meloxic
Long description: Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9089 - Bupivacaine implant, 1 mg
Long description: Bupivacaine, collagen-matrix implant, 1 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9090 - Plasminogen, human-tvmh 1 mg
Long description: Injection, plasminogen, human-tvmh, 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9091 - Sirolimus, protein-bound,1mg
Long description: Injection, sirolimus protein-bound particles, 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9092 - Inj., xipere, 1 mg
Long description: Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9093 - Inj., susvimo, 0.1 mg
Long description: Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg
Code added date: 20220401.
Code effective date: 20220701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9094 - Inj, sutimlimab-jome, 10 mg
Long description: Inj, sutimlimab-jome, 10 mg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9095 - Inj, tebentafusp-tebn, 1 mcg
Long description: Inj, tebentafusp-tebn, 1 mcg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9096 - Inj, releuko, 1 mcg
Long description: Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9097 - Inj, faricimab-svoa, 0.1 mg
Long description: Inj, faricimab-svoa, 0.1 mg
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9098 - Ciltacabtagene car pos t
Long description: Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Code added date: 20220701.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

C9101 - Inj, oliceridine 0.1 mg
Long description: Injection, oliceridine, 0.1 mg
Code added date: 20221001.
Code effective date: 20221001.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9113 - Inj pantoprazole sodium, via
Long description: Injection, pantoprazole sodium, per vial
Code added date: 20020101.
Code effective date: 20240701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9121 - Injection, argatroban
Long description: Injection, argatroban, per 5 mg
Code added date: 20030101.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9122 - Mometasone furoate (sinuva)
Long description: Mometasone furoate sinus implant, 10 micrograms (sinuva)
Code added date: 20200701.
Code effective date: 20210401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9130 - Injection, ivig bivigam
Long description: Injection, immune globulin (bivigam), 500 mg
Code added date: 20130401.
Code effective date: 20140101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9131 - In ado-trastuzumab emtansine
Long description: Injection, ado-trastuzumab emtansine, 1 mg
Code added date: 20130701.
Code effective date: 20140101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9132 - Kcentra, per i.u.
Long description: Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
Code added date: 20131001.
Code effective date: 20210701.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9133 - Factor ix recombinant
Long description: Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.
Code added date: 20140101.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9134 - Factor xiii a-subunit recomb
Long description: Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
Code added date: 20140701.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9135 - Factor ix (alprolix)
Long description: Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
Code added date: 20141001.
Code effective date: 20150101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9136 - Factor viii (eloctate)
Long description: Injection, factor viii, fc fusion protein, (recombinant), per i.u.
Code added date: 20150101.
Code effective date: 20150401.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9137 - Adynovate factor viii recom
Long description: Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

C9138 - Nuwiq factor viii recomb
Long description: Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
Code added date: 20160401.
Code effective date: 20170101.
Pricing Indicator Code(s): 53 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF